James F. Reddoch

Insider Reports History

Location: C/O Royalty Pharma Plc, 110 East 59 Th Street, New York, NY
Signature: /s/ Sean Weisberg, as Attorney-in-Fact for James F. Reddoch
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James F. Reddoch:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Royalty Pharma plc	EVP & Chief Scientific Officer	Class A Ordinary Shares	821K	$22.6M	$27.55	Sep 28, 2022	By Reddoch RPI LLC
Royalty Pharma plc	EVP & Chief Scientific Officer	Class A Ordinary Shares	25K	$690K	$27.55	Sep 28, 2022	By IRA
Royalty Pharma plc	EVP & Chief Scientific Officer	LP interests in RPI US Partners 2019, LP	479K			Aug 12, 2022	By Reddoch RPI LLC

Showing 1 to 3 of 3 entries

Insider Reports Filed by James F. Reddoch

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
RPRX	Royalty Pharma plc	Sep 28, 2022	2	-$4.12M	4	Sep 30, 2022	EVP & Chief Scientific Officer
RPRX	Royalty Pharma plc	Jun 8, 2022	1	-$4.16M	4	Jun 10, 2022	EVP & Chief Scientific Officer
RPRX	Royalty Pharma plc	May 27, 2022	1	-$3.08M	4	May 31, 2022	EVP & Chief Scientific Officer
RPRX	Royalty Pharma plc	May 19, 2022	1	-$3.03M	4	May 23, 2022	EVP & Chief Scientific Officer
RPRX	Royalty Pharma plc	Sep 10, 2021	1	$0	4	Dec 30, 2021	EVP, Research & Investments
RPRX	Royalty Pharma plc	Jul 26, 2021	1	-$356K	4	Jul 27, 2021	EVP, Research & Investments
RPRX	Royalty Pharma plc	Jul 26, 2021	1	-$356K	4	Jul 27, 2021	EVP, Research & Investments
RPRX	Royalty Pharma plc	Jul 12, 2021	3	-$753K	4	Jul 14, 2021	EVP, Research & Investments
RPRX	Royalty Pharma plc	Jul 6, 2021	3	-$3.09M	4	Jul 8, 2021	EVP, Research & Investments
RPRX	Royalty Pharma plc	Jun 4, 2021	4	-$9.11M	4	Jun 8, 2021	EVP, Research & Investments
RPRX	Royalty Pharma plc	Jun 2, 2021	1	-$2.11M	4	Jun 4, 2021	EVP, Research & Investments
RPRX	Royalty Pharma plc	May 7, 2021	2	$0	4	May 11, 2021	EVP, Research & Investments